Search

Search Constraints

You searched for: Author/Creator Hutton, Michael

Search Results

1. [O2–14–04]: AGGREGATE‐SELECTIVE ANTI‐TAU ANTIBODY MC‐1 DEMONSTRATED ROBUST IN VITRO AND IN VIVO ACTIVITY TO NEUTRALIZE TRANSMISSIBLE TAU AND REDUCE TAU PATHOLOGY. (1st July 2017)

2. Development and validation of two clinical prediction models to inform clinical decision-making for lumbar spinal fusion surgery for degenerative disorders and rehabilitation following surgery: protocol for a prospective observational study. Issue 5 (22nd May 2018)

8. MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentation. Issue 1 (1st January 2017)

9. O1‐08‐03: CHARACTERISATION OF TAU FROM P301S MOUSE REVEALS THAT SEED COMPETENT TAU COMPRISE SMALL FIBRILS COMPOSED OF HYPERPHOSPHORYLATED TAU. (1st July 2014)

10. O1‐10‐03: COMBINATION THERAPY WITH A PLAQUE‐SPECIFIC ABETA ANTIBODY AND BACE INHIBITOR RESULTS IN DRAMATIC PLAQUE LOWERING IN AGED PDAPP TRANSGENIC MICE. (1st July 2014)